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Abstract
Human T-lymphotropic virus type 1 (HTLV-I) is an important global health problem in the world mainly in the
endemic areas of HTLV-I infection. It was previously reported that Mashhad, in northeastern Iran, is a new endemic
region of HTLV-I. The aim of this study was to examine the prevalence and phylogenetic analysis of HTLV-I in
Sabzevar, located in the southeast of Mashhad. In this cross-sectional study 1445 individuals were selected by
multistage cluster sampling. Serum samples were screened for anti-HTLV-I antibody using enzyme-linked im-
munosorbent assay (ELISA); all of the ELISA-positive samples were confirmed by polymerase chain reaction (PCR).
Long terminal repeat (LTR) sequencing was carried out to determine the type of HTLV-I in Sabzevar. In the
primary screening by ELISA, 26/1445 (1.8%) of those sampled were reactive for HTLV-I antibody. Twenty-four out
of 26 samples were confirmed HTLV-I infection by PCR (24/1445). The overall prevalence of HTLV-I infection in
Sabzevar is 1.66%. The prevalence of the virus infection in men and women was 2.42% (11/455) and 1.31% (13/
989), respectively. Seroprevalence was associated with age, increasing significantly among those older than 30 years
( p= 0.015), and a history of surgery ( p= 0.002), imprisonment ( p= 0.018), and hospitalization ( p= 0.005). Three out
of 24 positive HTLV-I samples were selected for sequencing and phylogenetic analysis of LTR. The results showed
that HTLV-I in Sabzevar belonged to the cosmopolitan subtype. The present study showed Sabzevar is a new
endemic area for HTLV-I infection. Our study emphasizes that systemic HTLV-I screening of blood donors in
Sabzevar and other cities in Khorasan province is important and should be taken into account.
Introduction
Human T-lymphotropic virus type 1 (HTLV-I) is anenvelope, double-stranded RNA type C retrovirus that is
associated with two main type of diseases: HTLV-I-associated
myelopathy/tropical spastic paraparesis (HAM/TSP) and
adult T cell leukemia (ATL).1,2 Infection with HTLV-I is one of
the important global health problems, particularly in the en-
demic areas of HTLV-I infection. It is known that HTLV-I has
spread worldwide; however, it is endemic only in distinct re-
gions such as southwestern Japan,3,4 the Caribbean islands,5
Central and South America,6,7 and west of Africa.8
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We have previously reported that the northeast of Iran,
Mashhad, the capital of Razavi Khorasan province, is a new
endemic region of the virus and the prevalence of HTLV-I
infection is estimated to be 2.1% in the general population and
0.44% in blood donors.9,10 Epidemiologic studies in other
parts of Iran estimated the prevalence of HTLV-I infection to
be 0.34% in the general population of Uromia in the northwest
and 0.62% in Chaharmahal and Bakhtiari in the south-
west.11,12
Furthermore, studies in some specific populations of Iran
including both thalassemics and hemodialysis patients have
shown high HTLV-I prevalence in these subjects (about
6.8%).12 The high prevalence of HTLV-I infection has also
been reported in thalassemic patients in Shiraz (1.25%) and
Zahedan (1.6%).13,14 Phylogenetic analysis of the viral DNA
sequence has indicated that the HTLV-I present in Mashhad
belongs to the HTLV-I cosmopolitan "A" subtype.15
The sporadic cases of HTLV-I carriers and HAM/TSP
patients in other cities of Razavi Khorasan province, in-
cluding Sabzevar, suggest that this virus could be present in
this city. The aim of this study was to investigate the prev-
alence of HTLV-I infection in Sabzevar, an important ancient
city in the northeast of Iran. Phylogenetic analysis was also
carried out to determine the type of the virus in this city. The
association between HTLV-I infection and risk factors of




This cross-sectional study was conducted in the city of
Sabzevar in 2008. From all 10 areas of the city according to the
Urban Health Centers registries, 1445 apparently healthy
residents were selected by multistage cluster sampling. Three
clusters in each area were selected proportional to their pop-
ulation. A questionnaire was provided for data collection on
demographic and clinical information and the risk factors for
HTLV-I acquisition. The study was approved by the ethics
committee of Mashhad University of Medical Sciences
(MUMS) and Sabzevar University of Medical Sciences. In-
formed consent was obtained from each participant or the
next of kin before any interview was conducted.
Serologic and confirmation tests
Sixmilliliters of venous blood samples was taken from each
individual. Serum was separated and DNA was extracted.
Both samples were kept at - 20C before using. Serum sam-
ples were screened for anti-HTLV-I antibody using enzyme-
linked immunosorbent assay (ELISA; Dia Pro Diagnostic bio
probe, Italy) according to the manufacturer’s instruction. All
of the ELISA-positive samples were confirmed by polymerase
chain reaction (PCR).
PCR was also carried out on all positive ELISA samples for
further confirmation of HTLV-I infection. Briefly, genomic
DNA was extracted from peripheral blood mononuclear cells
(PBMCs) using an available commercial kit (Blood mini kit,
Qiagen, Germany). PCR amplification was performed in a
25 ll reaction containing 20mM Tris-HCl (pH 8.4), 100mM
KCl, 2mM MgCl2, 200mM dNTPs, 0.5U Taq DNA poly-
merase, 10 pmol/ll of each specific primer Tax Forward (5¢-
AGGGTTTGGACAGAGTCTT-3¢), Tax anti-forward (re-
versed) (5¢-AAGGACCTTGAGGGTCTTA), LTR forward (5¢-
CATAAGCTCAGACCTCCGGG-3¢), LTR anti-forward (5¢-
GGATGGCGGCCTCAGGTAGG-3¢), and genomic DNA (50–
100 ng). PCR consisted of initial denaturation at 94C for
4min, followed by 35 cycles of 94C for 50 s, 60C for 50 s,
72C for 1min, and a final extension at 72C for 5min. PCR
products were analyzed on 2% agarose gel stained with
ethidium bromide, and evaluated under UV light. The sizes of
PCR products were estimated according to the migration
pattern of a 100-bp DNA ladder.
DNA sequencing and phylogenetic analysis
For sequencing and phylogenetic analysis, the long-
terminal repeat (LTR) region of proviral DNA was amplified
by PCR. The LTR proviral (777 bp) was divided into two
overlapping fragments (GenBank accession number J02029.1).
PCR amplification was performed in a 25ll reaction con-
taining 20mMTris-HCl (pH 8.4), 100mMKCl, 25mMMgCl2,
10mMdNTPs, 0.5U Taq DNA polymerase, and 10 lmol/liter
of each specific primer LTR-A (5¢-TTCTGACAATGACCA
TGAGC-3¢), LTR-A anti-forward (5¢-GCGCgTGAAGGAGA
GATG-3¢), LTR-B forward (5¢-GCTCGCATCTCTCCTTCAC-
3¢), and LTR-B anti-forward (5¢-CGCTACGGGAAAAg
ATTTGG-3¢). The protocol for PCR was as follows: initial
denaturation at 94C for 4min, followed by 35 cycles of 94C
for 45 s, 54C for 45 s, 72C for 1min, and a final extension at
72C for 7min. PCR products were purified and double-
stranded sequencing was carried out by Seq Lab Company,
Germany.
All the fragments that resulted from sequencing by both
LTR-AF/R and LTR-BA/F were combined to build the lon-
gest possible contig. Overlapping nucleotides in the binding
site for primers LTR-AR and LTR-BF were used for contig
assembly by Geneious software (Biomatters Ltd., Auckland,
New Zealand). This contig was finally used for BLAST search
and the first 50 or 25 hits were used for phylogenetic analysis.
The phylogenic (maximum likelihood) tree was built using
PHYLM v2.4.516 integrated inside Geneious software. The
model of nucleotides substitution was HKY85 and the sta-
bility (robustness) of the tree was evaluated by bootstrap test
with 100 data sets.
Statistic analyses
Descriptive data were summarized as mean, standard de-
viation, and/or percents and were analyzed by SPSS 16.0
using Chi square and t tests. In addition, logistic regression
analysis was applied to assess factors related to HTLV infec-
tion. A p value < 0.05 was considered statistically significant.
Results
A total of 1445 individuals ranging in age from 5 to 88 years
(mean age 36.6 – 15.6) were included in this study. Nine
hundred and ninety (68.5%) were women and 455 (31.5%)
were men; the ratio of women tomenwas 0.45. In the primary
screening by ELISA, 26 (1.8%) were reactive for HTLV-I an-
tibody. All positive samples were examined by PCR, of which
92.31% (24/26) were positive. According PCR results, the
overall prevalence of the HTLV-I infection in the study pop-
ulation was 1.66% (24/1445) (CI 95% 1.07–2.46). The HTLV-I
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rate of infection for men was 2.42% (11/455) and for women
was 1.31% (13/989). No significant differences in HTLV-I
seroprevalence were observed between men and women
( p= 0.12).
In univariate analysis (Table 1), seroprevalence was asso-
ciated with age, increasing significantly among those older
than 30 years ( p = 0.015), history of surgery ( p= 0.002), im-
prisonment ( p = 0.018), and hospitalization ( p = 0.005). In the
logistic regression analysis (Table 2), history of imprisonment
was the only variable that had a significant association with
the infection ( p= 0.004).
Three out of 24 positive HTLV-I samples were selected for
sequencing and phylogenetic analysis of LTR. The assembled
contig (HTLV-I/Sab-Ir, isolated from Sabzevar, Iran) turned
out to be a subgroup with cosmopolitan subgroup HTLV-Ia
along with the sequences previously reported to have origi-
nated from Iran, Kuwait, andMashhadi Jews in Israel (Fig. 1).
These records were clustered together and became separated
from the other BLAST hits reported from the other parts of the
world including Central Africa, South Africa, Peru, Japan, the
United States, and Brazil.17–25 HTLV-I/Sab-Ir was 100%
similar [BLAST search E-value = 0, Score = 756, Bitscore =
1397.19, Identities = 756/756 (100%), Positives = 756/756
(100%), Gaps= 0/756 (0%)] to nucleotides 924–1679 of record
AF003010 in GenBank, which was isolated from an Iranian
patient with mycosis fungoides in Germany.26 In alignment
analysis, three to five mismatches were detected between
HTLV-I/Sab-Ir and the other hits with the same geographic
origin including Mashadi Jews. The presence of an A in motif
CCCCCTAAAGACAA instead of G is the signature of all
these hits from Iran, Kuwait, and Mashadi Jews in Israel. This
change removed the restriction site for a few enzymes in-
cluding Eco57I, AcuI, Eco57MI, MboII, BbsI, BpiI, BpuAI, and
Bstv2I. The presence of a G rather than an A in motif
ATGTTTGTCGAGCCGCCCT is the other common feature
among these hits, which was shared with hits AY040796 and
AY818430 isolated from natives of British Colombia in Ca-
nada and one patient in Central Africa, respectively (Fig. 2).
This change, however, creates a restriction site for TaqI,
BplI, CviJI, and CviKI-1. HTLV-I/Sab-Ir was highly similar
(99%) to the record AY818430 [Blast search E-value = 0,
Score= 742, Bitscore = 1371.33, Identities = 752/757 (99%),
Positives = 752/757 (99%), Gaps = 0/757 (0%)]. This record
represents the LTR region of the HTLV-I strain 2472LE LTR
isolated from a patient in Central Africa and belongs to the
only globally disseminated HTLV-I.27
Discussion
Several sporadic cases of a T cell leukemia link to HTLV-I
have been reported among immigrants to Israel and Germany
who were from Mashhad.28,29 It has been reported that 0.3–
3.4% of the general population in Iran was infected with this
virus.30 So far, Neishabour (3.4%) andMashhad (3%) have the
highest HTLV-I prevalence rate in Iran.31,32 However, the
infection rates and the risk factors associated with HTLV-I
infection in other important cities in the vicinity to Mashhad
have not been assessed. Routine screening procedures of
HTLV-I in blood donors in Khorasan Razavi province by the
Blood Transfusion Center inMashhad indicated that the virus
Table 1. Sociodemographic and Clinical Factors
Related to HTLV-I Infection in the General
Population of Sabzevar, Iran, 2009
Variable No. Positive (%) p-value
Sex
Male 455 2.42
Female 989 1.31 0.128
Age (years)




‡ 50 311 0.96 0.015
Marital status
Single 312 0.96
Married 1132 1.86 0.274
Literacy
Illiterate 278 0.72
Primary school 378 2.12
Secondary school 239 2.09
High school 423 1.65
Academic 125 1.60 0.688
Ethnic background
Fars 1426 1.68
Othersa 18 0 1.000
Twin birth
Yes 62 3.23
No 1378 1.60 0.327
Breast feeding
Yes 1398 1.57
No 46 4.35 0.176
History of surgery
Yes 530 3.02
No 914 0.88 .002
History of dentistry procedure
Yes 944 2.12
No 500 0.80 0.62
History of traditional cupping
Yes 150 3.33
No 1294 1.47 0.91
History of tattooing
Yes 22 0
No 1421 1.69 1.000
History of imprisonment
Yes 13 15.38
No 1431 1.54 0.018
History of drug abuse
Yes 24 8.33
No 1420 1.55 0.059
History of hospitalization
Yes 929 2.37
No 515 0.39 0.005
aIncluding Turk, Kurd, and Arab.
Table 2. Logistic Regression Analysis
of the Association of HTLV-1 Infection
with Selected Variables, Sabzevar, Iran, 2009
Variable p-value OR 95% CI
Age ‡ 30 0.125 2.64 0.76–9.16
History of surgery 0.151 2.00 0.78–5.14
History of imprisonment 0.004 10.50 2.10–52.63
History of hospitalization 0.161 3.15 0.63–15.68
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is present in Sabzevar; thus, we examined the ser-
oepidemiology of HTLV-I infection in a large representative
sample of individuals of all ages selected from all districts in
Sabzevar. The results demonstrated that the overall preva-
lence of HTLV-I infection was 1.66%; therefore, this city is
considered to be a new endemic region of HTLV-I in Iran.
Phylogenetic analysis showed that the HTLV-I subtype cir-
culating in Sabzevar belonged to the cosmopolitan subtype,
suggesting that the origin of the virus is the same as in
Mashhad.
Sabzevar is the second largest city in the Razavi Khorasan
province and it is approximately 220 km west of Mashhad
(Fig. 3). The Royal Road (the major road in the Persian Em-
pire), the Ritual Road, the Silk Road, and the Eurasian Route
passed through Khorasan province and its cities, especially
Mashhad and Sabzevar. This city was completely ruined after
the attack of the Mongols and reconstructed many times
throughout history. Sabzevar has become one of the fastest
growing cities in the provincewith an estimated population of
214,582 in 2006. The entry of the HTLV-I virus in Mashhad,
Neishabour, and Sabzevar is not clear; however, it seems that
the virus may have entered through one of the following
route: trade and skill road, an invading group such as the
Mongols, pilgrims to the holy Muslim shrine, and African
slaves.9 Slavery seems more likely to have introduced the
virus to these cities, because it has been widely practiced even
before the rise of Islam in these cities. It has been suggested
that the endemicity of the virus depends on variable factors
such as environmental, social, behavioral, and cultural.33
Despite the common origin and similarity of the virus in the
region, different prevalences of HTLV-I have been reported in
countries near Iran such as Kuwait, Iraq, and Turkmeni-
stan.34–36 Furthermore, the social interaction among countries
such as international trade, tourism, and pilgrimage seems to
be playing a pivotal role in virus distribution.37 In fact, the real
reason for the extreme variation of the prevalence of HTLV-I
in the continents, the countries, or even in different parts of a
country is a challenging issue; thus, it is difficult to explain the
FIG. 1. Phylogenic analysis for the long terminal repeat (LTR) region of HTLV-I provirus isolated from a sample of patients
in Sabzevar, Iran. DNA extraction, PCR amplification of the LTR region, and purification of PCR product were carried out.
DNA was then sequenced and the overlapping fragments were assembled in a 787-nucleotide contig using Geneious soft-
ware. This contig was used for a BLAST search and the geographic origin of each BLAST hit was extracted from either the
comments inside the GenBank record or from the literature in which the sequence was published. The unrooted phylogenic
(maximum likelihood) tree was built using the PHYLM algorithm integrated inside Geneious software. The position of
HTLV-I/Sab-Ir is indicated by an arrow in the tree. The geographic region from with the majority of hits in each cluster have
been reported is also mentioned next to each cluster. Branches are labeled with the accession number of each hit in GenBank
followed by the geographic origin. Bootstrap proportion values are shown for each branch.
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difference in the prevalence of HTLV-I in Mashhad and Sab-
zevar, although it is more likely that pilgrimage might have a
role in this issue. Therefore, it is necessary to perform large
seroepidemiologic studies in other cities of Khorasan province
to determine the seroprevalence of HTLV-I in this part of Iran.
Our results demonstrated that HTLV-I infection increases
with age, particularly among those older than 30 years; this is
similar to the previous cross-sectional study in Mashhad,
which suggested that HTLV-I prevalence increases among
those older than 35 years.9 It has been shown that HTLV-I
seroprevalence increases with age38,39 and is higher among
subjects more than 40 years than in those less than 40 years.40
Sexual contact is more likely to be the primary route of virus
transmission after age 30 years and breastfeeding during in-
fancy has a small role in HTLV-I transmission.41,42
Although the rate of infection is associated with age, other
variables such as marital status, breastfeeding, and literacy
are not risk factors for HTLV-I transmission. In this study, a
greater prevalence of infection was associated with impris-
onment, hospitalization, and a history of surgery, which is
consistent with previous studies that reported that the virus is
transmitted through contaminated needles and syringes
among injecting drug users and following surgery.43 HTLV-I
transmission has occurred following surgery; however, in-
come level, ethnic background, and place of birth had no
significant effect on the rate of HTLV-I infection.
In conclusion, the present study showed that Sabzevar is a
new endemic area for HTLV-I. It is clear that systemic HTLV-I
screening of blood donors in Sabzevar and the other cities of
Khorasan province should be taken into account. Further-
more, HTLV-I screening of pregnant women in this city will
decrease the risk of HTLV-I infection and appropriate coun-
seling regarding the risk of HTLV-I transmission by prolonged
breastfeeding can be recommended for those pregnantwomen
who are infected by the virus. Educational programs in Sab-
zevar are needed to prevent HTLV-I sexual transmission for
FIG. 2. Alignment view of the phylogenetic tree. The variations among hits from the Middle East region (Iran, Kuwait, and
Mashhadi Jews in Israel) and other parts of the world are highlighted.
FIG. 3. Mashhad and Sabzevar geographic location.
http://en.wikipedia.org/wiki/Sabzevar (coordinates: 3612¢N
5743¢E).
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those who are of a sexually active age. Considering the risks
associated with HTLV-I infection, similar seroepidemiologic
studies need to be conducted in other parts of Khorasan
province to identify the prevalence of the virus in this region of
Iran as a first step toward controlling the infection.
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